Robert L Stephens1, Ye Xu1, Robert J Volk2, Lawrence E Scholl1, Stephanie L Kamin1, E Wayne Holden3, Leonardo A Stroud4. 1. Macro International Inc. 2. Department of Family and Community Medicine, Baylor College of Medicine. 3. RTI International, Research Triangle Park. 4. Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention.
Abstract
OBJECTIVE: To examine the impact of a decision aid (DA) designed to promote informed decision making for screening with the prostate-specific antigen (PSA) test and to test a theoretical model of factors influencing decisional conflict. DESIGN: Structural equation modeling examined pathways between DA exposure, knowledge, schema, prostate cancer risk perceptions, decisional anxiety, and decisional conflict. Sample participants included 200 men from the general population (exclusive of African Americans) and 200 African American men. Half of the men in each subsample were randomly assigned to receive the DA. MAIN OUTCOME MEASURES: Decisional conflict regarding prostate cancer screening. RESULTS: The DA influences level of decisional conflict by increasing patient knowledge. This effect of knowledge on decisional conflict is indirect, however, through an association with greater perceived risk and lower decisional anxiety. Also, positive PSA schema was associated with lower decisional anxiety and decisional conflict. It is important that exposure to the DA had no impact on PSA schema. CONCLUSION: Schemas about testing must be considered in developing messages about the risks and benefits of testing. If schemas are counter to message content, mechanisms for modifying schemas must be incorporated into interventions.
RCT Entities:
OBJECTIVE: To examine the impact of a decision aid (DA) designed to promote informed decision making for screening with the prostate-specific antigen (PSA) test and to test a theoretical model of factors influencing decisional conflict. DESIGN: Structural equation modeling examined pathways between DA exposure, knowledge, schema, prostate cancer risk perceptions, decisional anxiety, and decisional conflict. Sample participants included 200 men from the general population (exclusive of African Americans) and 200 African American men. Half of the men in each subsample were randomly assigned to receive the DA. MAIN OUTCOME MEASURES: Decisional conflict regarding prostate cancer screening. RESULTS: The DA influences level of decisional conflict by increasing patient knowledge. This effect of knowledge on decisional conflict is indirect, however, through an association with greater perceived risk and lower decisional anxiety. Also, positive PSA schema was associated with lower decisional anxiety and decisional conflict. It is important that exposure to the DA had no impact on PSA schema. CONCLUSION: Schemas about testing must be considered in developing messages about the risks and benefits of testing. If schemas are counter to message content, mechanisms for modifying schemas must be incorporated into interventions.
Authors: Joel E Pacyna; Carmen Radecki Breitkopf; Sarah M Jenkins; Erica J Sutton; Caroline Horrow; Iftikhar J Kullo; Richard R Sharp Journal: J Med Genet Date: 2018-12-22 Impact factor: 6.318
Authors: Michael J Hall; Sharon L Manne; Gary Winkel; Daniel S Chung; David S Weinberg; Neal J Meropol Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-06 Impact factor: 4.254
Authors: Masahito Jimbo; Gurpreet K Rana; Sarah Hawley; Margaret Holmes-Rovner; Karen Kelly-Blake; Donald E Nease; Mack T Ruffin Journal: CA Cancer J Clin Date: 2013-03-15 Impact factor: 508.702